These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4017098)

  • 1. [Regional differences in drug utilization].
    Foltán V; Majtás J
    Cesk Zdrav; 1985 May; 33(5):221-7. PubMed ID: 4017098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Economic aspects of the long-term development of a variety of drugs in Czechoslovakia].
    Federmann J; Honzáková L
    Cesk Zdrav; 1981 May; 29(5):212-8. PubMed ID: 7249130
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of the relation between drug utilization and selected indicators. I].
    Kolár J; Döményová E; Vlcková J
    Cesk Zdrav; 1987 Sep; 35(8-9):371-8. PubMed ID: 3664781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Individual analyses of prescriptions in a district].
    Pavlů J; Curík J
    Cesk Zdrav; 1970 Apr; 18(4):189-92. PubMed ID: 5443986
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the utilization coefficient for drugs].
    Bonda J
    Pharm Prax; 1966; 7():165-7. PubMed ID: 6001090
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of drug costs within diagnosis related groups.
    Kolar R; Stanaszek W; Osborne J; Dougherty K
    Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Medicaid drug cost control experiences.
    Kennard LH; Platt WG
    Med Mark Media; 1979 Mar; 14(3):38, 40-3. PubMed ID: 10316799
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of retail prices on drug consumption].
    Federmann J; Cechová M; Partis J
    Cesk Zdrav; 1972; 20(12):458-67. PubMed ID: 4666281
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of cost sharing on the demand for prescription drugs in Belgium.
    van Doorslaer E
    Acta Hosp; 1984; 24(3):69-81. PubMed ID: 10268808
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of seasonal allergic rhinitis: cost implications of pharmacotherapy for managed care.
    Trotter JP
    Manag Care Interface; 2000 Jan; 13(1):60-2. PubMed ID: 10747693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Our experiences with checking prescriptions by means of computer technic].
    Jirátko K; Lukastík R
    Cesk Gynekol; 1972 Dec; 37(9):669-70. PubMed ID: 4642258
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutting costs by targeting prescribing practices.
    Rapoport D
    CMAJ; 1994 Jul; 151(1):13-4; author reply 14-5. PubMed ID: 8004552
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 14. A lab-pharmacy push to cut drug therapy costs.
    Rydzewski MM
    MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396
    [No Abstract]   [Full Text] [Related]  

  • 15. An approach to regulating cephalosporin use and costs.
    Ryan JL; Francese J
    Hosp Formul; 1980 Sep; 15(9):674-6. PubMed ID: 10248357
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parallels in drug utilization--II].
    Majtás J
    Cesk Zdrav; 1990 Jun; 38(5):209-20. PubMed ID: 2393936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug cost containment in the hospital.
    Smith WE
    Hosp Formul; 1978 Sep; 13(9):695-8. PubMed ID: 10238490
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs, physicians, and hospitalization.
    Zweifel P
    Adv Health Econ Health Serv Res; 1984; 5():311-37. PubMed ID: 10272995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug utilization decisions should be based on cost-benefit data].
    Bengt J; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
    [No Abstract]   [Full Text] [Related]  

  • 20. P&T Committee antibiotic cost considerations.
    Rinehart JR
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.